PANTHERx® Specialty Pharmacy is pleased to announce that it has received full reaccreditation from URAC, pursuant to Specialty Pharmacy, Version 3.0. This accreditation is a reflection of PANTHERx®’s unwavering commitment to Uncompromising Quality in our patient care. “It’s necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are […]

PANTHERx® Specialty Pharmacy, The Rare Disease SP®, is honored to be the recipient of the 2018 APPA “Specialty Pharmacy of the Year Award” and Chairman & CEO, Dr. Gordon J. Vanscoy, will be accepting this recognition and presenting the keynote speech on Rare Disorders and Orphan Drugs at the upcoming APPA PharmaCon Expo from June […]

PANTHERx® Specialty Pharmacy, The Rare Disease SP®, has once again earned the #1 ranking in the quarterly Patient Satisfaction Survey from Zitter Health Insights for the fourth quarter of 2017.  This ranking is based on the nearly 30 Specialty Pharmacies that received a statistically relevant sample of survey responses. PANTHERx® also received the first annual […]

PANTHERx® Specialty Pharmacy’s Fellowship program was featured in an article published by Specialty Pharmacy Continuum on April 11, 2018. The fellowship is designed to help address an emerging need in pharmacy – professionals with experience and specializations in both the business and clinical aspects of specialty pharmacy. During the fellowship, the fellows rotate through different […]